These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 27706402)

  • 1. [Sanitary regulation as part of health policy in Brazil: gaps and challenges].
    Maia C; Guilhem D
    Rev Panam Salud Publica; 2016 May; 39(5):226-231. PubMed ID: 27706402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Protagonism of the Brazilian Health Regulatory System in the Evolution of Patient Safety in the Country: History, Dilemmas, and Current Challenges.
    Santana HT; Costa MMM; Nogueira MDSP; Dos Santos ACRB; Carvalho AA; Morelo LT; Ribeiro CFM; de Sousa FC; de Moura HLCA; Barros LS; de Oliveira LSC; Gonçalves MRS
    J Patient Saf; 2020 Dec; 16(4):e260-e266. PubMed ID: 32084092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Construction of the Brazilian Sanitary Surveillance System: arguments to debate].
    De Seta MH; Dain S
    Cien Saude Colet; 2010 Nov; 15 Suppl 3():3307-17. PubMed ID: 21120315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional-based Integrated Healthcare Network policy in Brazil: from formulation to practice.
    Vargas I; Mogollón-Pérez AS; Unger JP; da-Silva MR; De Paepe P; Vázquez ML
    Health Policy Plan; 2015 Jul; 30(6):705-17. PubMed ID: 24963157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Integral care, a SUS (Brazilian Unified Health System) guideline for the sanitary surveillance].
    O'Dwyer G; Reis DC; da Silva LL
    Cien Saude Colet; 2010 Nov; 15 Suppl 3():3351-60. PubMed ID: 21120323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health protection in Brazil: the National Sanitary Surveillance System.
    Seta MH; Oliveira CVDS; Pepe VLE
    Cien Saude Colet; 2017 Oct; 22(10):3225-3234. PubMed ID: 29069179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Institutional change and political decision-making in the creation of the Brazilian National Health Surveillance Agency.
    Piovesan MF; Labra ME
    Cad Saude Publica; 2007 Jun; 23(6):1373-82. PubMed ID: 17546328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementing International Health Regulation (2005) in the Brazilian legal-administrative system.
    Lima YO; Costa EA
    Cien Saude Colet; 2015 Jun; 20(6):1773-83. PubMed ID: 26060955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should ANVISA be permitted to reject pharmaceutical patent applications in Brazil?
    Mueller LL; Taketsuma Costa SM
    Expert Opin Ther Pat; 2014 Jan; 24(1):1-4. PubMed ID: 24206261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Health surveillance: foundations, interfaces and tendencies].
    Arreaza AL; de Moraes JC
    Cien Saude Colet; 2010 Jul; 15(4):2215-28. PubMed ID: 20694344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing policy-makers', academics' and experts' satisfaction with the performance of the Palestinian health research system: a qualitative study.
    AlKhaldi M; Abed Y; Pfeiffer C; Haj-Yahia S; Alkaiyat A; Tanner M
    Health Res Policy Syst; 2018 Jul; 16(1):66. PubMed ID: 30045746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Theoretical and conceptual considerations about the work in sanitary surveillance, as a specific field of the work in health].
    Souza GS; Costa EA
    Cien Saude Colet; 2010 Nov; 15 Suppl 3():3329-40. PubMed ID: 21120321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The challenges of nanotechnology for the sanitary vigilance of medication].
    Batista Ade J; Pepe VL
    Cien Saude Colet; 2014 Jul; 19(7):2105-14. PubMed ID: 25014290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer policy framework for: public health assessment of carcinogens in the environment.
    DeRosa CT; Stevens YW; Johnson BL
    Toxicol Ind Health; 1993; 9(4):559-75. PubMed ID: 8296311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory Impact Analysis: a new tool for better regulation at ANVISA.
    Alves FN; Peci A
    Rev Saude Publica; 2011 Aug; 45(4):802-5. PubMed ID: 21779641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Federative coordination and decentralization: Brazilian experience in health.
    Viana AL; Machado CV
    Cien Saude Colet; 2009; 14(3):807-17. PubMed ID: 19547780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Definition of priority medicines for monitoring laboratory quality in Brazil: the interface between health surveillance and the National Drug Policy].
    Pontes Junior DM; Pepe VL; Osorio-de-Castro CG; Massena EP; Portela MC; Miranda Mdo C; Silva RS
    Cad Saude Publica; 2008 Sep; 24(9):2081-90. PubMed ID: 18813684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An analysis of the major challenges and obstacles for international technical cooperation in health, Brazil-Mozambique.
    Pereira EMB
    Cien Saude Colet; 2017 Jul; 22(7):2267-2276. PubMed ID: 28724008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccines in Brazil: historical analysis of the Sanitary registration and vaccine availability in the Brazilian Unified Health System.
    Peres KC; Buendgens FB; Prates EA; Bonetti NR; Soares L; Vargas-Peláez CM; Farias MR
    Cien Saude Colet; 2021 Nov; 26(11):5509-5522. PubMed ID: 34852086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges for the formulation, implantation and implementation of a National Health Surveillance Policy in Brazil.
    Guimarães RM; Meira KC; Paz EPA; Dutra VGP; Campos CEA
    Cien Saude Colet; 2017 May; 22(5):1407-1416. PubMed ID: 28538913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.